BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.25M | -25.94M | -20.17M | -21.56M | -12.93M |
| Total Depreciation and Amortization | 63.00K | 69.00K | 49.00K | 58.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.14M | 1.36M | 2.85M | 3.32M | 3.06M |
| Change in Net Operating Assets | -5.99M | -3.74M | 1.23M | -1.79M | -7.53M |
| Cash from Operations | -24.05M | -28.25M | -16.04M | -19.97M | -17.36M |
| Capital Expenditure | -26.00K | -112.00K | -22.00K | -159.00K | -426.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.73M | -14.32M | 12.86M | -15.48M | -77.56M |
| Cash from Investing | -46.75M | -14.43M | 12.84M | -15.64M | -77.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50M | -1.50M | -1.50M | -1.50M | -1.50M |
| Issuance of Common Stock | 126.02M | 17.87M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -807.00K | -356.00K | -44.00K | -- | -- |
| Cash from Financing | 123.72M | 16.01M | -1.54M | -1.50M | -1.50M |
| Foreign Exchange rate Adjustments | -27.00K | -19.00K | -10.00K | -46.00K | -12.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.89M | -26.69M | -4.76M | -37.16M | -96.86M |